• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/19

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

19 Cards in this Set

  • Front
  • Back
Receptor specificity for all sympathomimetic special agents (cocaine, tyramine, ephedrine, amphetamine, methamphetamine, phenmetrazine, methylphendia, modafinil, pemoline, phenylpropanolamine)?
indirect
MOA for cocaine?
inhibition of neurotransmitter uptake at catecholaminergic synapses
Kinetics for cocaine?
readily enters CNS, amphetamine-like effects
Clinical use for cocaine?
local reduction of blood flow
Toxicity for cocaine?
restlessness, dizziness, tremor, hyperactive reflexes, anxiety, delirium, libido changes, paranoid hallucination, panic states, suicidal tendencies
MOA for tyramine?
stimulates release of catecholamines
Kinetics for tyramine?
found in food, Beer, beans cheese, meets, wine and yeast. Inactivated by MAO
Clinical use for tyramine?
none
Toxicity for tyramine?
catecholamine excess especially when taken with MAO inhibitors
MOA for ephedrine?
stimulates release of catecholamines and directly activates adrenoreceptors
Kinetics for ephedrine?
non-catechol = well absorbed and good CNS penetration. Long duration of action
Clinical use for ephedrine?
nasal decongestant, asthma, chronic orthostatic hypotension, long term pressor effects
Toxicity for ephedrine?
anorexia, insomnia, hypertension, arrhythmias
MOA for amphetamine, methamphetamine, phenmetrazine, methylphenidate, modafinil and pemoline?
stimulates release of catecholamines and blocks reuptake
Kinetics for amphetamine, methamphetamine, phenmetrazine, methylphenidate, modafinil and pemoline?
non-catechol = well absorbed and good CNS penetration. Long duration of action
Clinical use for amphetamine, methamphetamine, phenmetrazine, methylphenidate, modafinil and pemoline?
anorexiant, ADHD, narcolepsy
Toxicity foramphetamine, methamphetamine, phenmetrazine, methylphenidate, modafinil and pemoline?
restlessness, dizziness, tremor, hyperactive reflexes, anxiety, delirium, libido changes, paranoid hallucination, panic states, suicidal tendencies
MOA for phenylpropanolamine?
weak sympathomimetic activity
Clinical use for phenylpropanolamine?
weight reduction, OTC